Category | Count | % |
---|
Extended LOS | 18 | 100.0% |
FFP | 12 | 66.7% |
RBC | 10 | 55.6% |
Vit K | 10 | 55.6% |
Steroids | 8 | 44.4% |
PLT | 8 | 44.4% |
IVIG | 7 | 38.9% |
Plasmapheresis | 5 | 27.8% |
Chemotherapy | 3 | 16.7% |
- LOS – Length of stay; FFP – fresh frozen plasma; Vit K – vitamin K; IVIG – intravenous immune globulin; PLT – platelets; RBC – red blood cells
- Interventions among the 18 bleeding patients for whom case reports contained documentation of managing immune-mediated coagulopathy [6, 7, 9, 10, 15–17, 20, 23, 26, 27, 30, 31, 33, 34].